Literature DB >> 10631333

Application of real-time radiation dosimetry using a new silicon LET sensor.

T Doke1, T Hayashi, J Kikuchi, S Nagaoka, T Nakano, T Sakaguchi, K Terasawa, G D Badhwar.   

Abstract

A new type of real-time radiation monitoring device, RRMD-III, consisting of three double-sided silicon strip detectors (DSSDs), has been developed and tested on-board the Space Shuttle mission STS-84. The test succeeded in measuring the linear energy transfer (LET) distribution over the range of 0.2 keV/micrometer to 600 keV/micrometer for 178 h. The Shuttle cruised at an altitude of 300 to 400 km and an inclination angle of 51.6 degrees for 221.3 h, which is equivalent to the International Space Station orbit. The LET distribution obtained for particles was investigated by separating it into galactic cosmic ray (GCR) particles and trapped particles in the South Atlantic Anomaly (SAA) region. The result shows that the contribution in dose-equivalent due to GCR particles is almost equal to that from trapped particles. The total absorbed dose rate during the mission was 0.611 mGy/day; the effective quality factor, 1.64; and the dose equivalent rate, 0.998 mSv/day. The average absorbed dose rates are 0.158 mGy/min for GCR particles and 3.67 mGy/min for trapped particles. The effective quality factors are 2.48 for GCR particles and 1.19 for trapped particles. The absorbed doses obtained by the RRMD-III and a conventional method using TLD (Mg(2)SiO(4)), which was placed around the RRMD-III were compared. It was found that the TLDs showed a lower efficiency, just 58% of absorbed dose registered by the RRMD-III.

Entities:  

Keywords:  NASA Center JSC; NASA Discipline Radiation Health; NASA Program Biomedical Research and Countermeasures

Mesh:

Substances:

Year:  1999        PMID: 10631333     DOI: 10.1016/s0027-5107(99)00130-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  1 in total

1.  Human nasal olfactory epithelium as a dynamic marker for CNS therapy development.

Authors:  Rita Sattler; Yoko Ayukawa; Luke Coddington; Akira Sawa; David Block; Richard Chipkin; Jeffrey D Rothstein
Journal:  Exp Neurol       Date:  2011-09-16       Impact factor: 5.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.